aluminum sulfate has been researched along with Malaria, Falciparum in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coban, C; Ishii, KJ; Keister, DB; Klinman, DM; Kumar, N; Stowers, AW | 1 |
| Birkett, AJ; Calvo-Calle, JM; Corado, ML; Maier, C; Nardin, EH; Oliveira, GA; Sarpotdar, P; Schmidt, A; Thornton, GB; Wetzel, K | 1 |
| Barnwell, JW; Collins, WE; Galland, GG; Lal, AA; Nace, D; Roberts, J; Shi, YP; Sullivan, JS; Tongren, JE; Udhayakumar, V; Williams, T | 1 |
| Audran, R; Bouzidi, A; Corradin, G; Druilhe, P; Mejia, P; Oeuvray, C; Roussilhon, C; Singh, S; Soesoe, D; Spertini, F | 1 |
| Barr, PJ; Bathurst, IC; Kaslow, DC; Keister, DB; Lensen, T; Ponnudurai, T | 1 |
| Calvo-Calle, JM; Clavijo, P; Nardin, EH; Nussenzweig, R; Oliveira, GA; Rose, K; Simon, R; Zeng, W | 1 |
| Biswas, S; Chopra, N; Rao, DN; Sabhnani, L; Thomas, B | 1 |
| Gozar, MM; Kaslow, DC; Keister, DB; Kensil, CR; Muratova, O; Price, VL | 1 |
| Cortés, J; Gascón, AR; Guzmán, F; Hernández, RM; Igartua, M; Patarroyo, ME; Pedraz, JL; Rodríguez, R; Rosas, JE | 1 |
2 trial(s) available for aluminum sulfate and Malaria, Falciparum
| Article | Year |
|---|---|
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.
Topics: Adolescent; Adult; Alum Compounds; Amino Acid Sequence; Animals; Antibodies, Protozoan; Double-Blind Method; Epitopes; Hepatitis B; Hepatitis B Core Antigens; Humans; Interferon-gamma; Malaria Vaccines; Malaria, Falciparum; Middle Aged; Molecular Sequence Data; Plasmodium falciparum; Protozoan Proteins; T-Lymphocytes; Vaccines, Synthetic; Virion | 2004 |
A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibody Formation; B-Lymphocytes; Cell Proliferation; Humans; Immunologic Memory; Malaria Vaccines; Malaria, Falciparum; Mannitol; Oleic Acids; Plasmodium falciparum; T-Lymphocytes | 2005 |
7 other study(ies) available for aluminum sulfate and Malaria, Falciparum
| Article | Year |
|---|---|
Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Protozoan; Antibody Affinity; Immunization; Immunization, Secondary; Malaria Vaccines; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Plasmodium falciparum; Protozoan Proteins | 2004 |
Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Aotidae; Disease Models, Animal; Drug Combinations; Female; Freund's Adjuvant; Hematocrit; Immunization Schedule; Lipid A; Malaria Vaccines; Malaria, Falciparum; Male; Plasmodium falciparum; Polymers; Saponins; Treatment Outcome; Vaccines, Synthetic | 2005 |
Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.
Topics: Adjuvants, Immunologic; Adsorption; Alum Compounds; Animals; Antibodies, Monoclonal; Antibodies, Protozoan; Aotidae; Base Sequence; Escherichia coli; Malaria, Falciparum; Mice; Molecular Sequence Data; Plasmodium falciparum; Protozoan Proteins; Recombinant Proteins; Saccharomyces cerevisiae; Zygote | 1994 |
Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
Topics: Adjuvants, Immunologic; Alum Compounds; Amino Acid Sequence; Animals; Chemical Phenomena; Chemistry, Physical; Cysteine; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Malaria Vaccines; Malaria, Falciparum; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Oximes; Plasmodium falciparum; Protozoan Proteins; Vaccines, Synthetic | 1998 |
Inducing protective antibodies against ring-infected erythrocyte surface peptide antigen of Plasmodium falciparum using immunostimulating complex (ISCOMs) delivery.
Topics: Alum Compounds; Animals; Antibodies, Protozoan; Erythrocytes; Female; H-2 Antigens; Haplotypes; Immunoenzyme Techniques; Immunoglobulin G; ISCOMs; Malaria Vaccines; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred Strains; Peptide Fragments; Plasmodium falciparum; Protozoan Proteins; Vaccination | 2000 |
Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Protozoan; Enzyme-Linked Immunosorbent Assay; Hydrogen-Ion Concentration; Immunization, Secondary; Malaria Vaccines; Malaria, Falciparum; Mice; Plasmodium falciparum; Protozoan Proteins; Rabbits; Recombinant Fusion Proteins; Saponins; Vaccines, Synthetic | 2001 |
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
Topics: Alum Compounds; Animals; Antibodies, Protozoan; Antigens, Protozoan; Aotus trivirgatus; Biocompatible Materials; Drug Delivery Systems; Lactic Acid; Malaria Vaccines; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Microspheres; Plasmodium falciparum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Protozoan Proteins; Recombinant Proteins; Vaccines, Synthetic | 2002 |